Episode Details

Back to Episodes

The Health Marketing Daily | Long-term melatonin use linked to 90% | Censurata pubblicità dell'integratore UROCYST Active: diciture | Arla plans more ingredients capex amid

Published 1 month ago
Description
The Health Marketing Daily — August 30, 2026 In this episode: • A major new study linking long-term melatonin use to a 90% higher heart failure risk will force supplement marketers and retailers to reassess how they position one of the world's best-selling sleep supplements. • Italy's advertising self-regulator has censured the marketing of supplement UROCYST Active for making misleading claims and using health claims that have never been authorised — a sharp reminder of the compliance risks facing supplement brands across Europe. • Arla's CEO has flagged 'super high' demand for protein ingredients and committed to significant new capital investment — a strong commercial signal that the protein ingredient supply chain is entering a new phase of expansion to meet booming wellness-driven demand. • New research finding a link between even small daily intakes of artificial sweeteners and cognitive decline puts fresh pressure on functional food and drink brands that use these ingredients — and could accelerate consumer demand for naturally sweetened wellness products. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us